Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Autism Res. 2015 Nov 4;9(2):184–203. doi: 10.1002/aur.1567

Table 2.

Published Reports of Therapeutic Use of TMS in ASD

Paper Diagnosis Intellectual
Disability
n (ASD) Mean age
(years)
Gender Medication Site Coil Frequency Intensity Duration
Sokhadze et al. [2009], Journal of
  Autism and Developmental Disorders
  (RCT with waitlist control)
Autism None 13 (8rTMS,
  5 waitlist)
17 M L dlPFC (5cm anterior to
  M1)
Fo8 0.5 Hz 90% RMT 10 min
Baruth et al. [2010], Journal of
  Neurotherapy (RCT with waitlist control)
ASD 2 25 (16rTMS,
  9 waitlist)
14 M/F L & R dlPFC (5cm ante-
  rior to M1)
Fo8 1 Hz 90% RMT 10 min
Sokhadze et al. [2010], Applied
  Psychophysiology and Biofeedback
  (Clinical trial with no control)
Autism None 13 16 M/F L dlPFC (5cm anterior to
  M1)
Fo8 0.5 Hz 90% RMT 10 min
Enticott et al. [2011], Journal of ECT
  (Single case study)
AS None 1 20 F None Bilateral dmPFC (7cm
  anterior to M1)
H-coil 5 Hz 100% RMT 15 min
Fecteau et al. [2011], European Journal
  of Neuroscience (Crossover trial with
  sham control)
AS None 10 37 M/F None L & R pars opercularis, L
  & R par triangularis
  (MRIneuronaviga
  tion), sham (central
  lobe midline)
Fo8 1 Hz 70% of
  stimulator
  output
30 min
Casanova et al. [2012], Translational
  Neuroscience (RCT with waitlist control)
ASD None 45 (25 rTMS,
  20 waitlist)
13 M/F - L & R dlPFC (5cm ante-
  rior to M1)
Fo8 1 Hz 90% RMT 10 min
Enticott et al. [2012], Brain Stimulation
  (Crossover trial with sham control)
ASD (6
  HFA, 5 AS)
None 11 18 M/F - SMA (15%of nasion to
  inion anterior to Cz),
  L M1,
Sham (M1)
Fo8 1 Hz 100% RMT 15 min
Niederhofer [2012], Clinical Neuropsychiatry
  (Single case study with placebo)
Autism Not reported 1 42 F None M1 1 Hz 1 hr
Sokhadze et al. [2012], Applied Psychophysiology
  and Biofeedback (RCT with waitlist control)
ASD (36
  HFA, 4 AS)
None 40 (20 rTMS,
  20 waitlist)
14 M/F L & R dlPFC (5cm ante-
  rior to M1)
Fo8 1 Hz 90% RMT 10 min
Panerai et al. [2013], Autism ((i) Crossover trial
  with sham; (ii) RCT with sham; (iii) crossover
  trial with sham iv) RCT (TMS, EHI training,
  TMS + EHI training))
Autism Severe to
  profound
(i) 9
(ii) 17
(iii) 4
(iv) 13
(i) 14
(ii) 13
(iii) 16
(iv) 13
M (i) left and right PrMC
  (2.5 cm anterior to
  M1)
(ii), (iii), iv) left PrMC
Fo8 (i) 8 Hz, 1 Hz
(ii) 8 Hz,
1 Hz (iii),
(iv) 8 Hz
90% RMT 8 Hz 30 min,
1 Hz
15 min;
Enticott et al. [2014], Brain Stimulation
  (RCT with sham control)
ASD (4
HFA, 24 AS)
None 28 (15active,
  13 sham)
33 M/F Yes (39%) dmPFC (7cm anterior to
  M1)
H-coil 5 Hz 100% RMT 15 min
Cristancho et al. [2014], Journal of ECT
  (Single case study)
Autism,
  Depression
Not reported 1 15 M olanzapine,
  fluoxetine,
  guanfacine,
  clonazepam
(i) R DLPFC
(6cm anterior to M1),
  (ii) L DLPFC
(6cm anterior to M1)
Fo8 1 Hz 0% RMT Variable
  (between
  5 to 25 min)
Casanova et al. [2014], Frontiers in Human
  Neuroscience (Proof of feasibility study,
  no control)
ASD None 18 13 M/F L & R dlPFC (5cm ante-
  rior to M1)
Fo8 5 Hz 90% RMT 10 min
Sokhadze et al. [2014a], Frontiers in
  Systems Neuroscience (RCL with
  waitlist control)
ASD None 27 14.5 M/F L & R dlPFC (5cm ante-
  rior to M1)
Fo8 1 Hz 90% RMT 10 min
Sokhadze et al. [2014b], Appl Psychophysiol
  Biofeedback (Clinical trial with waitlist
  control)
ASD None 42 14.5 M/F L & R dlPFC (5cm ante-
  rior to M1)
Fo8 1 Hz 90% RMT 10 min
Paper Trains Pulses
Delivered
Sessions Blinding Measures Assessment Times Reported Effects Side Effects
Sokhadze et al. [2009],
  Journal of Autism and
  Developmental
  Disorders
15 × 10 sec,
  20–30 sec ISI
150 6 None EEG Gamma power Accuracy,
  RT (Kanizsa), Abberant
  Behavior Checklist (ABC),
  Social Responsiveness
  Scale (SRS) (Caregiver-
  report),
Repetitive Behavior Scale-
  Revised (RBS-R)
Before and two
  weeks after treat-
  ment course
Decreased frontal EEG P3a amplitude
  to non-targets following TMS
Decreased centro-parietal latency
  EEG P3b to nontarget and non-
  Kanizsa following TMS
Decrease in gamma power for non-
  target and non-Kanizsa following
  TMS
Reduced repetitive behavior (RBS-R)
  following TMS
Baruth et al. [2010],
  Journal of
  Neurotherapy
15 × 10 sec,
  20–30 s ISI
150 12 (6 L, 6 R) None EEG Gamma power Accuracy,
  RT (Kanizsa), Abberant
  Behavior Checklist (ABC),
  Social Responsiveness
  Scale (SRS) (Caregiver-
  report),
Repetitive Behavior Scale-
  Revised (RBS-R)
Before and two
  weeks after treat-
  ment course
Increased EEG gamma power to tar-
  gets, decrease to nontargets
Reduced repetitive behavior (RBS-R)
  Reduced irritability (ABC)
Itching sensation at
  nose (5)
Mild headache (1)
Sokhadze et al. [2010],
  Applied Psychophysi-
  ology and
  Biofeedback
15 × 10 sec,
  20–30 sec ISI
150 6 None EEG event-related potentials
  (visual oddball) Accuracy,
  RT (Kanizsa) Abberant
  Behavior Checklist (ABC)
  Social Responsiveness
  Scale (SRS) (Caregiver-
  report) Repetitive Behavior
  Scale-Revised (RBS-R)
Before and two
  weeks after treat-
  ment course
Reduced error rate
Increased frontal EEG P50 amplitude
  to targets
Increased frontal EEG P50 latency to
  targets
Decreased frontal EEG N200 latency
  to novel distractors
Decreased parieto-occipital EEG P50
  to novel distractor
Increased centro-parietal EEG P50 to
  targets and decreased to standard
  distractor
Centro-parietal EEG P3b amplitude
  increase to targets and decrease to
  standard distractors
Centro-parietal EEG P200 increased
  latency to targets
Reduced repetitive behaviors (RBS-
  R)
Enticott et al. [2011],
  Journal of ECT
30 × 10 sec,
  20 sec ISI
1500 10 Double IRI, AQ, RAADS Before, after, and
  one-month after
  treatment course
Reduction on all measures Anecdotal
  reports of improvement from
  patient and relatives
None
Fecteau et al. [2011],
  European Journal of
  Neuroscience
1 1800 1 per site Double Response latency on Boston
  Naming Test
Before and after TMS Increased response latency after L
  pars opercularis
Decreased response latency after L
  pars triangularis
Many reported,
  including: Sleepy,
  Trouble concen-
  trating, Improved
  mood, Headache,
  Dizziness
Casanova et al. [2012],
  Translational
  Neuroscience
15 × 10 sec,
  20–30 sec ISI
150 12 (6 L, 6 R) None EEG event-related potentials
  (ERP) Accuracy, RT
  (Kanizsa), Abberant
  Behavior Checklist (ABC),
  Social Responsiveness
  Scale (SRS) (Caregiver-
  report), Repetitive Behav-
  ior Scale - Revised (RBS-
  R)
Before and two
  weeks after treat-
  ment course
Reduced error rate Increased frontal
  EEG N200 to targets
Reduced frontal EEG N200 latency
  Increased frontal RHEEG P300 to
  targets
Increased parietal EEG N200 to tar-
  gets, Reduced repetitive behavior
  (RBS) Reduced irritability (ABC)
Enticott et al. [2012],
  Brain Stimulation
1 900 1 per site Single EEG movement-related corti-
  cal potentials Motor
  response time
Before and after TMS SMA: increased early EEG component
  PMC: increased EEG negative slope
Niederhofer [2012], Clin-
  ical Neuropsychiatry
1 1200 5 Single Abberant Behavior Checklist
  (ABC)
Before and after
  treatment course
ABC Irritability: Active 40 to 33,
  Sham 39 to 35, ABC Sterotypy:
  Active 18 to 12, Sham 16 to 15
Sokhadze et al. [2012],
  Applied Psychophysi-
  ology and
  Biofeedback
15 × 10 sec,
  20–30 sec ISI
150 12 (6 L, 6 R) None EEG event-related potentials
  (ERPs) RT
Accuracy (Kanizsa)
Before and after
  treatment course
Reduced omission error rates
  Increased EEG ERN amplitude
  Reduced EEG ERN latency
Panerai et al. [2013],
  Autism
8 Hz 30 × 3.6 sec,
56.4 sec ISI
900 i) 3;
ii) 10;
iii) 5 active,
5 sham,
5 active,
5 sham; iv) 10
Double (i), (ii), (iii), (iv) Psycho-
  educational Profile-
  Revised (PEP-R) eye-hand
  coordination;
Before and after
  treatment course
(i), (ii), (iii) improved eye-hand
  coordination score following lPrMC
  HF TMS iv) Improved eye-hand
  coordination score following com-
  bined TMS + EHI training compared
  to each technique alone
Enticott et al. [2014],
  Brain Stimulation
30 × 10 sec,
  20 sec ISI
1500 10 Double Interpersonal Reactivity
Index (IRI)
Autism Spectrum Quotient
  (AQ)
Ritvo Autism-Aspergers Diag-
  nostic Scale (RAADS)
Reading the Mind in the
  Eyes Test (RMET)
  Mentalizing
Animations Task
Before, after, and
  one-month after
  treatment course
Reduced social relatedness (RAADS)
  Reduced personal distress (IRI)
1. “light-
  headedness”
2. facial discomfort
  during rTMS
Cristancho et al. [2014],
  Journal of ECT
(i) 15 × 10 sec,
  10–30 sec
ISI (week 1), 30 ×
  10 sec, 10–30 sec
  ISI (week 2),
  (ii) 30–60 × 10 sec,
  10–15 sec ISI
(i) 150–300,
(ii) 300–600
(i) 10, (ii) 26 None Mental status examination Before and after
  treatment course
Anecdotal reports of improve mood,
  eye contact, interpersonal commu-
  nication, verbal expression, focus,
  activity
Mild headaches, jaw
  twiching, tran-
  sient dizziness
Casanova et al. [2014],
  Frontiers in Human
  Neuroscience
8 × 10 sec,
  20 sec ISI
160 18 None Aberrant Behavior Checklist,
  restricted Behavior Pat-
  tern, Time- domain meas-
  ures of HRV (R-R interval,
  SDNN, RMSSD, pNN50),
  Frequency –domain meas-
  ures of HRV (LV and HF of
  HRV, LF/HF ratio index),
  SCL
Before and 2 weeks
  after treatment
Increase in R-R interval, SDNN, and
  HF power. Significant decrease in
  the LF/HF ratio and SCL. Signifi-
  cant improvements in RBS-R and
  ABC rating scores.
None
Sokhadze et al. [2014a],
  Frontiers in Systems
  Neuroscience
9 × 20 sec,
  20–30 sec ISI
180 18 None Aberrant Behavior Checklist
  (ABC), Repetitive Behav-
  ior Scale (RBS-R), EEG
  event related potentials
  (ERPs), RT and post-error
  RT
Before and after Decreased irritability and hyperactiv-
  ity on the Aberrant Behavior
  Checklist (ABC), and decreased
  stereotypic behaviors on the
  Repetitive Behavior Scale (RBS-R).
  Decreased amplitude and pro-
  longed latency in the frontal and
  fronto-central N100, N200, and
  P300 (P3a) ERPs to non-targets.
  Increased amplitude of P2d (P2a
  to targets minus P2a to non-tar-
  gets) and centro-parietal P100
  and P300 (P3b) to targets.
  Decrease in latency and increase
  in negativity of ERN during com-
  mission errors.
None
Sokhadze et al. [2014b],
  Appl Psychophysiol
  Biofeedback
9 × 20 sec,
  20–30 sec ISI
180 18 None Aberrant Behavior Checklist,
  Repetitive Behavior Scale-
  Revised, EEG Gamma
  power, Theta/Beta ratio,
  RT and Accuracy, Post-
  error RT, EEG event
  related potentials (ERPs)
Before and after Integrated TMS-NFB treatment
  enhanced the process of target
  recognition. Significant improve-
  ments in RBS-R and ABC rating
  scores. Improvement in both early
  and later stage ERP indices.
None

ASD, Autism Spectrum Disorder; HFA, High Functioning Autism; AS, Asperger’s Syndrome; M1, Primary Motor Cortex; dlPFC, Dorsolateral Prefrontal Cortex; dmPFC, Dorsomedial Prefrontal Cortex; Fo8, Figure of 8 coil; ISI, Interstimulus Interval; rTMS, Repetitive Transcranial Magnetic Stimulation; RMT, Resting Motor Threshold.